Open AccessEstimating the Cost of Point-of-Care Early Infant Diagnosis in a Program Setting: A Case Study Using Abbott m-PIMA and Cepheid GeneXpert IV in Zimbabwe
Author(s) -
Sushant Mukherjee,
Jennifer Cohn,
Andrea Ciaranello,
Emma Sacks,
Oluwarantimi Adetunji,
Addmore Chadambuka,
Haurovi Mafaune,
McMillan Makayi,
Nicole C McCann,
Esther Turunga
Publication year - 2020
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0000000000002371
Subject(s) - genexpert mtb/rif , renting , medicine , environmental health , business , operations management , tuberculosis , economics , engineering , mycobacterium tuberculosis , pathology , civil engineering
Point-of-care early infant diagnosis (POC EID) increases access to HIV test results and shortens time to result-return and antiretroviral therapy initiation, as compared to central laboratory-based EID. However, to scale-up POC EID, governments need more information about programmatic costs.